These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38462823)

  • 81. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.
    Reveille JD; Hwang MC; Danve A; Kafka S; Peterson S; Lo KH; Kim L; Hsia EC; Chan EKH; Deodhar A
    Clin Rheumatol; 2021 Apr; 40(4):1331-1341. PubMed ID: 32926247
    [TBL] [Abstract][Full Text] [Related]  

  • 83. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures.
    Kolotkin RL; Norquist JM; Crosby RD; Suryawanshi S; Teixeira PJ; Heymsfield SB; Erondu N; Nguyen AM
    Health Qual Life Outcomes; 2009 Jun; 7():53. PubMed ID: 19505338
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Psychometric Validation of the Haemo-QOL-A in Participants with Hemophilia A Treated with Gene Therapy.
    Quinn J; Delaney KA; Wong WY; Miesbach W; Bullinger M
    Patient Relat Outcome Meas; 2022; 13():169-180. PubMed ID: 35879931
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study.
    Doherty MK; Leung Y; Su J; Naik H; Patel D; Eng L; Kong QQ; Mohsin F; Brown MC; Espin-Garcia O; Vennettilli A; Renouf DJ; Faluyi OO; Knox JJ; MacKay H; Wong R; Howell D; Mittmann N; Darling GE; Cella D; Xu W; Liu G
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29905764
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.
    Berntorp E; LeBeau P; Ragni MV; Borhany M; Abajas YL; Tarantino MD; Holstein K; Croteau SE; Liesner R; Tarango C; Carvalho M; McGuinn C; Funding E; Kempton CL; Bidlingmaier C; Cohen A; Oldenburg J; Kearney S; Knoll C; Kuriakose P; Acharya S; Reiss UM; Kulkarni R; Witkop M; Lethagen S; Krouse R; Shapiro AD; Astermark J
    Haemophilia; 2022 May; 28(3):453-461. PubMed ID: 35263495
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Changes in health-related quality of life before and after a 12-month enhanced primary care model among chronically ill primary care patients in Australia.
    John JR; Tannous WK; Jones A
    Health Qual Life Outcomes; 2020 Aug; 18(1):288. PubMed ID: 32831086
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors.
    Scalone L; Mantovani LG; Mannucci PM; Gringeri A;
    Haemophilia; 2006 Mar; 12(2):154-62. PubMed ID: 16476090
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Health-related quality of life in children with haemophilia in China: a 4-year follow-up prospective cohort study.
    Zhang H; Huang J; Kong X; Ma G; Fang Y
    Health Qual Life Outcomes; 2019 Feb; 17(1):28. PubMed ID: 30728017
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
    Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects.
    Valentino LA; Rusen L; Elezovic I; Smith LM; Korth-Bradley JM; Rendo P
    Haemophilia; 2014 May; 20(3):398-406. PubMed ID: 24418368
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.
    Hoots WK; Ebbesen LS; Konkle BA; Auerswald GK; Roberts HR; Weatherall J; Ferran JM; Ljung RC;
    Haemophilia; 2008 May; 14(3):466-75. PubMed ID: 18282155
    [TBL] [Abstract][Full Text] [Related]  

  • 93. What to expect after open heart valve surgery? Changes in health-related quality of life.
    Borregaard B; Pedersen SS; Berg SK; Dahl J; Ekholm O; Sibilitz K; Zwisler ADO; Lauck SB; Kyte D; Calvert M; Riber LPS; Møller JE
    Qual Life Res; 2020 May; 29(5):1247-1258. PubMed ID: 31875308
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
    Oldenburg J; Mahlangu JN; Bujan W; Trask P; Callaghan MU; Young G; Asikanius E; Peyvandi F; Santagostino E; Kruse-Jarres R; Negrier C; Kessler C; Xu J; Windyga J; Shima M; von Mackensen S
    Haemophilia; 2019 Jan; 25(1):33-44. PubMed ID: 30427582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial.
    Delforge M; Patel K; Eliason L; Dhanda D; Shi L; Guo S; Marshall TS; Arnulf B; Cavo M; Nooka A; Manier S; Callander N; Giralt S; Einsele H; Ailawadhi S; Popa McKiver M; Cook M; Rodríguez-Otero P
    Lancet Haematol; 2024 Mar; 11(3):e216-e227. PubMed ID: 38423700
    [TBL] [Abstract][Full Text] [Related]  

  • 96. BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
    Konkle BA; Walsh CE; Escobar MA; Josephson NC; Young G; von Drygalski A; McPhee SWJ; Samulski RJ; Bilic I; de la Rosa M; Reipert BM; Rottensteiner H; Scheiflinger F; Chapin JC; Ewenstein B; Monahan PE
    Blood; 2021 Feb; 137(6):763-774. PubMed ID: 33067633
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
    Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
    Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Haemophilia: factoring in new therapies.
    Fassel H; McGuinn C
    Br J Haematol; 2021 Sep; 194(5):835-850. PubMed ID: 34322873
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
    Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
    Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial.
    Hammond NE; Finfer SR; Li Q; Taylor C; Cohen J; Arabi Y; Bellomo R; Billot L; Harward M; Joyce C; McArthur C; Myburgh J; Perner A; Rajbhandari D; Rhodes A; Thompson K; Webb S; Venkatesh B;
    Intensive Care Med; 2020 Sep; 46(9):1696-1706. PubMed ID: 32676679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.